<DOC>
	<DOCNO>NCT03053700</DOCNO>
	<brief_summary>This interventional prospective study . The study design evaluate additional benefit combination IPL treatment local application Bromonide 0.33 % gel treatment erythematotelangiectatic ( ETR ) papulopustular ( PPR ) .</brief_summary>
	<brief_title>Intense Pulsed Light Adjunctive Bromonidine Treatment Rosacea</brief_title>
	<detailed_description>Patients would treat full face application bromonide 0.33 % gel daily three month . In addition half patient ' face would subject three IPL treatment session three week apart .</detailed_description>
	<mesh_term>Rosacea</mesh_term>
	<criteria>patient ( male female ) must 18 yaers old age fulfil one following : 1 . Suffer ETR 2 . Suffer PPR 3 . Suffer combination ETR PPR . 1.Under 18 year old age . 2.Pregnant woman . 3.Systemic treatment rosacea previous six month enrollment . 4.Topical treatment rosacea previous one month enrollment . 5.Phymatous occular rosacae .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Rosacea , Bromonidine , intensed pulse light</keyword>
</DOC>